Previous research demonstrated the formulation's efficacy in improving bone health in osteoporosis models by upregulating osteogenic markers such as BMP‐2 and OPN (Lee et al. 2017; Wang et al. 2023). The gene discussed is BMP2; the disease is osteoporosis.